BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9700007)

  • 41. Congenital hypertrophy of retinal pigment epithelium: a sign of familial adenomatous polyposis.
    Chapman PD; Church W; Burn J; Gunn A
    BMJ; 1989 Feb; 298(6670):353-4. PubMed ID: 2538178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In patients with a positive family history of familial adenomatous polyposis can the condition be diagnosed from the presence of congenital hypertrophy of the retinal pigment epithelium detected via an eye examination: A systematic review.
    Rehan S; Aye K
    Clin Exp Ophthalmol; 2020 Jan; 48(1):98-116. PubMed ID: 31525261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Value of combined phenotypic markers in identifying inheritance of familial adenomatous polyposis.
    Giardiello FM; Offerhaus GJ; Traboulsi EI; Graybeal JC; Maumenee IH; Krush AJ; Levin LS; Booker SV; Hamilton SR
    Gut; 1991 Oct; 32(10):1170-4. PubMed ID: 1659551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The distinction between multiple retinal pigment epithelial hamartomata (MRPEH) in familial adenomatous polyposis (FAP) and congenital hypertrophy of the retinal pigment epithelium (CHRPE).
    Hennessy MP; Collins F; Coroneo MT
    Aust N Z J Ophthalmol; 1993 Nov; 21(4):275-6. PubMed ID: 8148147
    [No Abstract]   [Full Text] [Related]  

  • 45. Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines.
    Bapat BV; Parker JA; Berk T; Cohen Z; McLeod RS; Ray PN; Stern HS
    Dis Colon Rectum; 1994 Feb; 37(2):165-71. PubMed ID: 7905818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic heterogeneity of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in families with familial adenomatous polyposis.
    Hodgson SV; Bishop DT; Jay B
    J Med Genet; 1994 Jan; 31(1):55-8. PubMed ID: 8151639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive diagnosis in familial adenomatous polyposis: evaluation of molecular genetic and ophthalmologic methods.
    Caspari R; Friedl W; Böker T; Augustin A; Mandl M; Jaeger K; Gallkowski K; Propping P
    Z Gastroenterol; 1993 Nov; 31(11):646-52. PubMed ID: 8291275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Contribution of the ophthalmologist to presymptomatic diagnosis of familial adenomatous polyposis (FAP)].
    Sommer E; Hinkel GK; Friedl W
    Ophthalmologe; 1995 Dec; 92(6):809-16. PubMed ID: 8563429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A histopathologic study of the pigmented fundus lesions in familial adenomatous polyposis.
    Kasner L; Traboulsi EI; Delacruz Z; Green WR
    Retina; 1992; 12(1):35-42. PubMed ID: 1314407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Importance of the fundus oculi in the early diagnosis in childhood of familial polyposis coli].
    Díaz Llopis M; Monteagudo Montesinos E; Gutiérrez San Román C; Menezo Rozalen JL
    Cir Pediatr; 1988 Jan; 1(1):39-42. PubMed ID: 2856357
    [No Abstract]   [Full Text] [Related]  

  • 51. Hypertrophy of the retinal pigment epithelium associated with Gardner's syndrome.
    Blair NP; Trempe CL
    Am J Ophthalmol; 1980 Nov; 90(5):661-7. PubMed ID: 7446647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The presence of congenital hypertrophy of the retinal pigment epithelium in a subgroup of patients with adenomatous polyposis coli mutations.
    Reck AC; Bunyan D; Eccles D; Humphry R
    Eye (Lond); 1997; 11 ( Pt 3)():298-300. PubMed ID: 9373466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study of diagnostic value of congenital hypertrophy of retinal pigment epithelium in Chinese familial adenomatous polyposis patients.
    Cai S; Yu Y; Xie X; Huang Y; Song Y; Zhan S; Zheng S
    Eur J Cancer Prev; 2022 Sep; 31(5):422-429. PubMed ID: 35191403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Congenital hypertrophy of retinal pigment epithelium in patients with colonic polyps associated with cancer family syndrome.
    Houlston RS; Fallon T; Harocopos C; Williams CB; Davey C; Slack J
    Clin Genet; 1992 Jul; 42(1):16-8. PubMed ID: 1325301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Familial adenomatous polyposis (FAP): integration of clinical and genetic parameters in the screening of subjects at risk. A one-family example].
    Chautems R; Givel JC
    Swiss Surg; 1996; 2(5):196-200. PubMed ID: 8963844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Osteomatous jaw lesions in familial adenomatous polyposis].
    Reyes J; Llompart A; Barranco L; Gayà J; Forteza-Rey I; Obrador A
    Gastroenterol Hepatol; 2002; 25(6):387-91. PubMed ID: 12069700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Complex screening of family members at risk for familial adenomatous polyposis].
    Kristóf T; Tóth T; Ujszászy L; Juhász L; Korompai K; Minik K; Papp Z
    Orv Hetil; 1997 Dec; 138(50):3159-64. PubMed ID: 9446080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Congenital hypertrophy of the retinal pigment epithelium predicts colorectal polyposis in Gardner's syndrome.
    Traboulsi EI; Maumenee IH; Krush AJ; Alcorn D; Giardiello FM; Burt RW; Hughes JP; Hamilton SR
    Arch Ophthalmol; 1990 Apr; 108(4):525-6. PubMed ID: 2157384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diagnosis of familial adenomatous polyposis].
    Jirásek V
    Vnitr Lek; 2002 Jun; 48(6):552-5. PubMed ID: 12132358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperpigmented lesions of the retinal pigment epithelium in familial adenomatous polyposis.
    Baker RH; Heinemann MH; Miller HH; DeCosse JJ
    Am J Med Genet; 1988 Oct; 31(2):427-35. PubMed ID: 2852900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.